U.S. FDA Advisory Committee Votes Nine to One in Favor of Remestemcel-L (Ryoncil(TM)) for Efficacy in Children With Steroid-Refractory Acute Graft Versus Host Disease
NEW YORK, Aug 14, 2020 (GLOBE NEWSWIRE via COMTEX) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for...